In vivo adoptive transfer of CD4 + T helper cell type 1 clones reactive with autologous myelin basic protein (MBP) may initiate an inflammatory demyelinating disease of the central nervous system called experimental autoimmune encephalomyelitis. Although MBP is also a component of peripheral nervous system (PNS) myelin, previous studies have failed to demonstrate inflammation in the PNS induced by MBP-reactive T cells. Here, we report on two MBP-specific T cell clones that preferentially initiate inflammatory and demyelinating peripheral neuritis when adoptively transferred to syngeneic recipients. The MBP epitope recognized by these clones spans the junction of exons 6 and 7 and, therefore, is present in the 21-and 18.5-kD but not the 14-and 17-kD MBP isoforms, in which exon 5 is spliced to exon 7. The data suggest that MBP may be processed and presented differently in the central nervous system and PNS, and they provide evidence for MBP as a potential target for autoimmune reactions in the PNS.
W
idespread multifocal inflammation and demyelination of the peripheral nervous system (PNS) characterize both chronic and acute inflammatory demyelinating polyradiculoneuropathies. Indications that these diseases are of an autoimmune nature were supported by animal studies of experimental autoimmune neuritis (EAN), which can be experimentally induced by immunization with peripheral nerve tissue in adjuvant (1) . Investigations of the neuritogenic components of peripheral nerve demonstrated that EAN can be induced by immunization of rats with either the P0 or the P2 proteins of peripheral nerve myelin (2, 3) . EAN can be adoptively transferred to native recipients with CD4 + cells specific for either of these two myelin proteins (4, 5) .
In addition to the P0 and P2 proteins, peripheral nerve myelin contains a third major protein, designated Pl. The P0 and P2 proteins are unique to peripheral nerve myelin and constitute ",~45-65% and 2-15% of PNS myelin proteins, respectively (6, 7) . In contrast, the P1 protein is identical in amino acid sequence to central nervous system (CNS)-derived myelin basic protein (MBP) (8, 9) . Despite the presence of MBP in the PNS as well as in the CNS, MBP-recognizing T cell clones that passively transfer experimental autoimmune encephalomyelitis in mice have not been shown to induce peripheral nerve inflammation and demyelination (10, 11) .
The relative percentages of MBP in CNS and PNS myelin differ dramatically. While MBP accounts for 30-40% of myelin proteins in the CNS, it accounts for only 2-16% of peripheral nerve myelin proteins, with v~a'iations depending upon the precise location within the PNS (7) . Precise quantitative and qualitative comparisons of PNS and CNS MBP are further complicated by more recent findings of several MBP isoforms (12) (13) (14) (15) . In the fully developed mouse CNS, four isoforms of MBP, with molecular masses of 21.5, 18.5, 17.2, and 14 kD, predominate. While all major MBP isoforms present in the CNS are also present in the PNS, as judged by PCtL amplified cDNA synthesized from sciatic nerve RNA, their relative quantities in CNS various PNS are not known (16) .
MBP does, however; appear to play a role in certain instances of PNS disease. Inflammatory polyneuropathy has been shown, in some patients, to correlate with antibodies to MBP (17). Pender et al. have shown demyelination of spinal roots after adoptive transfer of MBP-sensitized lymphocytes to Lewis rat recipients (18) , although no involvement of dorsal root ganglia, spinal nerves, and peripheral nerves was observed.
We previously characterized encephalitogenic MBP-specific T cell clones from BALB/c mice (19, 20) . 12 out of 14 I-Aa-restricted clones recognizing an epitope in the 59-76 peptide of MBP were capable of causing severe autoimmune encephalomyelitis upon adoptive transfer into BALB/c recipients (19) . Histologically, severe inflammation and demyelination in the CNS were observed; no evidence of PNS involvement was found. In contrast, two I-Ea-restricted T cell clones recognizing an epitope present in the COOH-terminal region of MBP comprising residues 151-168 were shown to cause only moderate clinical and histological signs of disease (20) . Here we report that, although the latter two T cell clones induce moderate inflammation in the CNS, they induce significant PNS disease. The MBP epitope recognized by these clones spans an alternative MBP exon splice site.
Materials and Methods
Mice. Female BALB/c mice were purchased from Harlan Bioproducts for Science, Inc. (Indianapolis, IN) and used between the ages of 6-10 wk.
Antigens. Mouse T Cell Clones. The derivation and specificity of MBP-reactive BALB/c clones has been previously described (19, 20) . Clone A2 was derived from a BALB/c mouse immunized with MBP peptide 151-168 and selected in vitro with homologous peptide.
Assays of Antigen-specific Proliferative Responses and 11-,2. For
antigen-specific proliferation, triplicate cultures containing 5 x 104 cloned T cells were incubated with 5 x l0 s irradiated (3,000 R) spleen cells in the presence or absence of Ag as detailed elsewhere (19, 20) . Similarly, production of supematants and Ib2 assays were performed as described previously (19) . The means of triplicate cultures are presented. Standard deviations were <20%.
In Vivo Adoptive Transfer of l~'sease. T cell clones were activated in vitro for 3 h with irradiated syngeneic spleen cells, 10 t~g/ml MBP peptide, and 1I.-2. Cells were harvested, washed, and injected intravenously into lightly irradiated (390 R) BALB/c recipients. Immediately after cell injections, and again after 3 d, recipients were injected intravenously with 200 ng purified pertussis toxin (List Biological Laboratories, Inc., Campbell, CA).
Clinical and Histopathological Evaluation. Mice were monitored daily for clinical signs of disease and scored as follows: 0, no dinical signs; 1, complete tail limpness, incontinence and ruflq_ing of fur; 2, limp tail and moderate hind limb weakness; 3, complete hind limb paralysis; 4, complete hind limb paralysis and some forelimb weakness; and 5, moribund state.
For histopathological analysis, tissues from affected mice were fixed in Bouin's solution followed by 10% formalin before embedding in paraffin. Multiple cross sections of brain and spine, with spinal cord in situ, as well as sections of whole legs, were stained with hematoxylin and eosin. Replicate sections were stained with luxol fast blue and cresyl violet, and with Bodian stain for axons. The assignment of a severity score is on the basis of a semiquantitative evaluation of the extent of mononuclear cell infiltration and of demyelination.
Results and Discussion
BALB/c-derived T cell dories reactive with two distinct MBP epitopes were studied for their ability to induce inflammatory and demyelinating disease in syngeneic recipients. All clones used in these studies are Thls, secreting IL-2 and IFN-'y but not IL-4 after activation (19 and data not shown). 3 d after in vitro activation with syngeneic spleen cells and appropriate peptide antigens, 107 MBP-reactive T cell clones were injected intravenously into lightly irradiated (390-R) BALB/c recipients ( Table 1 ). The recipients developed signs of disease 7-14 d after transfer. Recipients of clones 1E2 and 2C2, specific for the COOH-terminal MBP peptide 151-168 in association with I-E d, showed ruffling of fur, significant and progressive weight loss, complete tail paralysis, and hind limb ataxia. Paralysis of a hind leg was observed in only 1 out of 11 1E2 recipients, but not among 13 2C2 recipients. These clinical signs appear modest compared with the paraplegia and tetraplegia consistently observed upon transfer of BALB/c-derived T cell clones recognizing the MBP 59-76 peptide in association with I-A a, such as clones 8-4.G6, 8-7.D8, and 8-3.E8.
Histological studies of CNS from recipients of MBP 151-168-specific clones 1E2 or 2C2 revealed only very mild CNS disease: Very few inflammatory loci were observed, and there was no evidence of demyelination (20 and Table 1 ). By contrast, recipients of clones recognizing the 59-76 peptide of MBP had numerous inflammatory loci accompanied by severe demyelination in CNS tissue (19 and In all recipients of clones 1E2 and 2C2, the most severely affected parts of the nervous system were peripheral nerves in the hind leg. Most nerves were diffusely and densely in- filtrated by mononuclear inflammatory cells, predominantly macrophages, with fewer lymphocytes (Fig. 1, A and B) . Only a few scattered areas of intact myelin remained (Fig. 1 B) . Bodian stains of severely inflamed nerves revealed a deficiency of axons, suggesting that they had undergone necrosis. More proximally, some larger nerves and spinal roots were unaffected, while others were partially demyelinated (Fig. 1, C 
and D). Examination of many cross sections of spinal cord revealed inflammation and partial demyelination in some spinal roots and loci of inflammatory cell infiltration in meninges.
Inflammation and demyelination were present in subpial white matter as well. All such loci were superficial and extended into the spinal cord only a short distance (Fig. 1 E) . Very rare small loci of inflammation were observed in the brains of a few animals, but demyelination in the brain was never observed (Fig. 1 F) .
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50000- MBP exists predominantly in four different isoforms in the adult nervous system (14, 15) . In the 14-and 17.2-kD isoforms, exon 5 is spliced directly to exon 7. The adult brain has over threefold more of the exon 5/7 spliced forms (14 and 17.2 kD) than 6/7 spliced forms (21 and 18.5 k.D) (12) . We synthesized a number of peptides of the MBP COOH terminus, shown in Table 2 , including one corresponding to exon 7 only (155-168), one consisting of 4 residues from exon 6 spliced to exon 7 (151-168, representing the 18 COOHterminal residues of the 21-and 18.5-kD isoforms), and one consisting of 4 residues from exon 5 spliced to exon 7 ("5/7"), representing the 17.2-and 14-kD isoforms. Epitope mapping using this series of COOH-terminal MBP peptides shows that the MBP epitope recognized by clones 1E2 and 2C2 lies within residues 151-168 and requires the junction of exons 6 and 7. Fig. 2 shows the proliferative responses and the patterns of IL-2 production by clones 1E2 and 2C2 to the series of synthetic COOH-terminal MBP peptides described. These data show that proliferative responses of clones 1E2 and 2C2 to peptide 155-168 (exon 7 only) require 100-fold more peptide as compared with their responses to 151-168. The requirement for exon 6 residues for optimal activation of these clones is confirmed by the data in Fig. 2 , showing that, without the exon 6 residues, production of IL-2 by clones 2C2 and 1E2 is not detectable. Furthermore, peptide "5/7" (111-114/155-168), representing the COOH-terminal residues of the 14-and 17.2-kD forms of MBP, was incapable of activating clones 1E2 and 2C2 either to proliferate or to produce IL-2 (Fig. 2) . Responses of A2, a clone which recognizes a sequence encoded within exon 7 alone and is unaffected by flanking sequences beyond the splice site, are included. Clone A2 responds equally to peptide 155-168 (exon 7 only) or to 155-168 with residues from either exons 5 or 6 on its NH2 terminus. Because clone A2 is also I-E d restricted (data not shown), these data confirm that peptide 5/7 is capable of binding to, and being presenting by, the relevant class II molecule.
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Despite the presence of MBP in peripheral nerve myelin (PO, encephalitogenic MBP-reactive T cell clones have not previously been shown to initiate peripheral nerve disease when adoptively transferred in vivo. Data presented here define a murine model of autoimmune peripheral neuritis, in which PNS MBP is the predominant target autoantigen for MBPrecognizing T cell clones.
There are a number of possible non-mutually exclusive explanations for the ability of clones 1E2 and 2C2 to induce disease primarily in the PNS. Because the epitope for these two clones spans an alternative MBP splice site, they appear to recognize MBP sequences present only in the 18.5-and 21-kD isoforms of MBP. In the CNS, the 17.2-and 14-kD isoforms, which contain the 5/7 splice site, are approximately threefold more abundant (12) . Possible quantitative differences in MBP isoform composition in the PNS and CNS could, at least partially, account for the preferential retention and activation of these clones in the PNS.
Another possibility is that differential processing of MBP by tissue-specific resident APCs may yield different epitopes. That different epitopes may be presented is made even more likely by the fact that MBP is endogenously synthesized by PNS Schwann cells, which have been shown to function as APC (21) . Moreno et al. reported that qualitatively different epitopes of hen egg lysozyme are generated when comparing exogenously provided to endogenously synthesized hen egg lysozyme (22) . Quantitative differences in I-Ed-restricted T cell activation by exogenous, compared with endogenous, fl2-microglobulin peptides have also been reported (23) . Intimately linked with "determinant selection" of epitopes is MHC class II expression. Quantitative differences in MHC class II expression on Schwann cells as compared with microglia and astrocytes could affect ligand presentation, particularly in the case of the 1E2 and 2C2 ligand, where the affinity between peptide and class II is relatively low (19) . Finally, unique trafficking and/or homing properties of these two clones may account for induction of PNS disease, although preferential retention and focus initiation are probably ultimately determined by optimal ligand (peptide/MHC) presentation.
In summary, this report provides the first demonstration that autoreactive MBP-recognizing T cell clones can preferentially induce inflammation and demyelination in the PNS. The data also highlight the differential recognition of MBP epitopes in the CNS and PNS and suggest that functional availability of antigenic epitopes is a determining factor in expression of autoimmunity.
